EcoDrugPlus

Coagulation Factor X

Ensembl ID : ENSDNOG00000001808
Gene Symbol: F10
2 Cross references
239 Possible Orthologues:

Coagulation Factor Xi

Ensembl ID : ENSDNOG00000007347
Gene Symbol: F11
2 Cross references
215 Possible Orthologues:

Coagulation Factor Xii

Ensembl ID : ENSDNOG00000013301
Gene Symbol: F12
4 Cross references
187 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSDNOG00000004875
Gene Symbol: CCDC6
2 Cross references
223 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSDNOG00000006156
Gene Symbol: CSF1R
2 Cross references
273 Possible Orthologues:

Complement C1s

Ensembl ID : ENSDNOG00000049074
Gene Symbol: C1S
2 Cross references
199 Possible Orthologues:

Complement C5

Ensembl ID : ENSDNOG00000014163
Gene Symbol: C5
2 Cross references
216 Possible Orthologues:

Corticosteroid 11-Beta-Dehydrogenase Isozyme 1-Like

Ensembl ID : ENSDNOG00000049472
Gene Symbol: LOC101438259
3 Cross references
267 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSDNOG00000039246
Gene Symbol: CRHR1
2 Cross references
208 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSDNOG00000041164
Gene Symbol: CCND1
2 Cross references
274 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSDNOG00000032169
Gene Symbol: CDK1
4 Cross references
246 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSDNOG00000043354
Gene Symbol: CDK2
4 Cross references
203 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).